In vitro evaluation of PHISIO-coated sets for pediatric cardiac surgery

Scand Cardiovasc J. 2009 Apr;43(2):129-35. doi: 10.1080/14017430802302316.

Abstract

Objectives: Phosphorylcholine coated cardiopulmonary bypass (CPB) circuits for children have been available for some years, but conflicting results regarding the inflammatory response have been reported. Accordingly, we aimed to investigate the effect of phosphorylcholine coating on the inflammatory response.

Design: Ten coated and nine uncoated pediatric CPB sets were tested in an in vitro CPB circuit model. The inflammatory response was assessed by serial assays of hemoglobin, hematocrit, leukocyte counts, platelet counts, activation of the complement system, activation of platelets measured as beta-thromboglobulin, activation of neutrophils measured as myeloperoxidase, activation of coagulation measured as prothrombin fragments 1+2, assessment of hemolysis measured as lactate dehydrogenase, and a panel of seven cytokines. Samples were obtained at baseline and after 15, 30, 60 and 120 minutes.

Results: There were no significant differences between the phosphorylcholine coated circuits and the uncoated circuits for any of the parameters during the observation period, although a potentially beneficial effect on platelets could not be ruled out.

Conclusions: Phosphorylcholine coating of CPB equipment did not exert any beneficial effect on the inflammatory markers monitored.

Publication types

  • Evaluation Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Blood Coagulation / drug effects
  • Cardiac Surgical Procedures*
  • Cardiopulmonary Bypass / adverse effects
  • Cardiopulmonary Bypass / instrumentation*
  • Child
  • Coated Materials, Biocompatible*
  • Complement Membrane Attack Complex / analysis
  • Cytokines / blood
  • Equipment Design
  • Hematocrit
  • Hemolysis / drug effects
  • Humans
  • Inflammation / blood
  • Inflammation / etiology
  • Inflammation / prevention & control*
  • Inflammation Mediators / blood
  • L-Lactate Dehydrogenase / blood
  • Leukocyte Count
  • Materials Testing
  • Peptide Fragments / analysis
  • Peroxidase / blood
  • Phosphorylcholine / pharmacology*
  • Platelet Count
  • Prothrombin / analysis
  • Time Factors

Substances

  • Biomarkers
  • Coated Materials, Biocompatible
  • Complement Membrane Attack Complex
  • Cytokines
  • Inflammation Mediators
  • Peptide Fragments
  • prothrombin fragment 1.2
  • Phosphorylcholine
  • Prothrombin
  • L-Lactate Dehydrogenase
  • Peroxidase